This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Influenza
and you are
between 6 and 49
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of the study is to get a better understanding of the natural and adaptive immune response to the flu virus and to compare the immune cell responses to FDA-licensed flu vaccines in nasal mucosal cells and in blood.

Provided treatments

  • Biological: Fluzone®
  • Biological: FluMist®
Tris trial is registered with FDA with number: NCT03028974. The sponsor of the trial is Stanford University and it is looking for 72 volunteers for the current phase.
Official trial title:
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection